Clinical Trial: Identification and Efficacy Evaluation of Minimal Residual Disease After Ablation of Lung Cancer: Based on Multi-Parameter Quantification of Photon-Counting CT and Deep Learning (China)

China, Sept. 23 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Identification and Efficacy Evaluation of Minimal Residual Disease After Ablation of Lung Cancer: Based on Multi-Parameter Quantification of Photon-Counting CT and Deep Learning'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133164

Registration Time: 2026/09/22

Type: Observational study

Primary Sponsor: Beijing Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=342312

Published by HT Digital Content Services with permission from Health Daily Digest....